Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
Sleep and Breathing
Published in: Sleep and Breathing 3/2014

01-09-2014 | Original Article

Adenotonsillectomy and orthodontic therapy in pediatric obstructive sleep apnea

Authors: Maria Pia Villa, Rosa Castaldo, Silvia Miano, Maria Chiara Paolino, Ottavio Vitelli, Alessandra Tabarrini, Anna Rita Mazzotta, Manuela Cecili, Mario Barreto

Published in: Sleep and Breathing | Issue 3/2014

Login to get access

Abstract

Purpose

Rapid maxillary expansion (RME) is an additional treatment in pediatric obstructive sleep apnea (OSA). The aim of this study was to present data about the outcome of adenotonsillectomy (AT) and of RME in a clinical sample of pediatric OSA.

Methods

We consecutively enrolled children with OSA to undergo RME or AT. The age and the severity of OSA are the main factors involved in the choice of treatment. A polysomnography was performed at the baseline (i.e., before treatment, T0) and 1 year after treatment (T1).

Results

A total of 52 subjects fulfilled the inclusion criteria. Twenty-five children underwent AT (group 1) and 22 children underwent RME (group 2). Five children underwent both treatments (group 3). Children in group 2 were older, had a longer disease duration, a higher body mass index (BMI), a lower apnea–hypopnea index (AHI), and a lower arousal index at T0 than children in group 1. After 1 year, BMI percentile and overnight mean saturation increased in group 1 while AHI and arousal index decreased. In group 2, mean overnight saturation increased while AHI decreased. Children in group 3 displayed a significant decrease in AHI from T0 to T1.

Conclusions

Our data demonstrate that both treatments help to improve OSA, and a multidisciplinary approach to treatment is suggested.
Literature
1.
Gozal D (1998) Sleep-disordered breathing and school performance in children. Pediatrics 102:616–620PubMedCrossRef
2.
Gozal D, Lipton AJ, Jones KL (2002) Circulating vascular endothelial growth factor levels in patients with obstructive sleep apnea. Sleep 25:59–65PubMed
3.
Gozal D, Kheirandish-Gozal L, Serpero LD, Sans Capdevila O, Dayyat E (2007) Obstructive sleep apnea and endothelial function in school-aged non obese children: effect of adenotonsillectomy. Circulation 116:2307–2314PubMedCrossRef
4.
Amin R, Somers VK, McConnell K, Willging P, Myer C, Sherman M, McPhail G, Morgenthal A, Fenchel M, Bean J, Kimball T, Daniels S (2008) Activity-adjusted 24-hour ambulatory blood pressure and cardiac remodeling in children with sleep disordered breathing. Hypertension 51:84–91PubMedCrossRef
5.
Marcus CL, McColley SA, Carroll JL, Loughlin GM, Smith PL, Schwartz AR (1994) Upper airway collapsibility in children with obstructive sleep apnea syndrome. J Appl Physiol 77:918–924PubMed
6.
Arens R, Marcus CL (2004) Pathophysiology of upper airway obstruction: a developmental perspective. Sleep 27:997–1019PubMed
7.
Redline S, Amin R, Beebe D, Chervin RD, Garetz SL, Giordani B, Marcus CL, Moore RH, Rosen CL, Arens R, Gozal D, Katz ES, Mitchell RB, Muzumdar H, Taylor HG, Thomas N, Ellenberg S (2011) The Childhood Adenotonsillectomy Trial (CHAT): rationale, design, and challenges of a randomized controlled trial evaluating a standard surgical procedure in a pediatric population. Sleep 34:1509–1517PubMedCentralPubMed
8.
Chan DK, Jan TA, Koltai PJ (2012) Effect of obesity and medical comorbidities on outcomes after adjunct surgery for obstructive sleep apnea in cases of adenotonsillectomy failure. Arch Otolaryngol Head Neck Surg 138:891–896PubMedCrossRef
9.
Brietzke SE, Gallagher D (2006) The effectiveness of tonsillectomy and adenoidectomy in the treatment of pediatric obstructive sleep apnea/hypopnea syndrome: a meta-analysis. Otolaryngol Head Neck Surg 134:979–984PubMedCrossRef
10.
Montgomery-Downs HE, Crabtree VM, Gozal D (2005) Cognition, sleep and respiration in at risk children treated for obstructive sleep apnoea. Eur Respir J 25:336–342PubMedCrossRef
11.
Stewart MG, Glaze DG, Friedman EM, Smith EO, Bautista M (2005) Quality of life and sleep study findings after adenotonsillectomy in children with obstructive sleep apnea. Arch Otolaryngol Head Neck Surg 131:308–314PubMedCrossRef
12.
Mitchell RB, Kelly J, Call E et al (2004) Quality of life after adenotonsillectomy for obstructive sleep apnea in children. Arch Otolaryngol Head Neck Surg 130:190–194PubMedCrossRef
13.
Mitchell RB, Kelly J, Call E, Yao N (2004) Long-term changes in quality of life after surgery for pediatric obstructive sleep apnea. Arch Otolaryngol Head Neck Surg 130:409–412PubMedCrossRef
14.
Tran KD, Nguyen CD, Weedon J, Goldestein NA (2005) Child behavior and quality of life in pediatric obstructive sleep apnea. Arch Otolaryngol Head Neck Surg 131:52–57PubMedCrossRef
15.
Flanary VA (2003) Long-term effect of adenotonsillectomy on quality of life in pediatric patients. Laryngoscope 113:1639–1644PubMedCrossRef
16.
Tauman R, Gulliver TE, Krishna J et al (2006) Persistence of obstructive sleep apnea syndrome in children after adenotonsillectomy. J Pediatr 149:803–808PubMedCrossRef
17.
Bhattacharjee R, Kheirandish-Gozal L, Spruyt K, Mitchell RB, Promchiarak J, Simakajornboon N, Kaditis AG, Splaingard D, Splaingard M, Brooks LJ, Marcus CL, Sin S, Arens R, Verhulst SL, Gozal D (2010) Adenotonsillectomy outcomes in treatment of obstructive sleep apnea in children: a multicenter retrospective study. Am J Respir Crit Care Med 182:676–683PubMedCrossRef
18.
Marcus CL, Moore RH, Rosen CL, Giordani B, Garetz SL, Taylor HG, Mitchell RB, Amin R, Katz ES, Arens R, Paruthi S, Muzumdar H, Gozal D, Thomas NH, Ware J, Beebe D, Snyder K, Elden L, Sprecher RC, Willging P, Jones D, Bent JP, Hoban T, Chervin RD, Ellenberg SS, Redline S, for the Childhood Adenotonsillectomy Trial (CHAT) (2013) A randomized trial of adenotonsillectomy for childhood sleep apnea. N Engl J Med 368:2366–2376PubMedCentralPubMedCrossRef
19.
Pirelli P, Saponara M, De Rosa C, Fanucci E (2010) Orthodontics and obstructive sleep apnea in children. Med Clin North Am 94:517–529PubMedCrossRef
20.
Guilleminault C, Huang YS, Glamann C, Li K, Chan A (2007) Adenotonsillectomy and obstructive sleep apnea in children: a prospective survey. Otolaryngol Head Neck Surg 136:169–175PubMedCrossRef
21.
Villa MP, Miano S, Rizzoli A (2011) Mandibular advancement devices are an alternative and valid treatment for pediatric obstructive sleep apnea syndrome. Sleep Breath 5:179–184CrossRef
22.
Guilleminault C, Monteyrol PJ, Huynh NT, Pirelli P, Quo S, Li K (2011) Adeno-tonsillectomy and rapid maxillary distraction in pre-pubertal children, a pilot study. Sleep Breath 15:173–177PubMedCrossRef
23.
Villa MP, Malagola C, Pagani J, Montesano M, Rizzoli A, Guilleminault C, Ronchetti R (2007) Rapid maxillary expansion in children with obstructive sleep apnea syndrome: 12-month follow-up. Sleep Med 8:128–134PubMedCrossRef
24.
Iber C, Ancoli-Israel S, Chesson A, Quan SF, for the American Academy of Sleep Medicine (2007) The AASM manual for the scoring of sleep and associated events: rules, terminology and technical specifications, 1st edn. American Academy of Sleep Medicine, Westchester, IL
25.
Cole TJ, Bellizzi MC, Flegal KM, Dietz WH (2000) Establishing a standard definition for child overweight and obesity worldwide: international survey. BMJ 6:1240–1243CrossRef
26.
Friedman M, Ibrahim H, Joseph NJ (2004) Staging of obstructive sleep apnea/hypopnea syndrome: a guide to appropriate treatment. Laringoscope 114:454–459CrossRef
27.
Marcus CL, Carroll JL, Koerner CB, Hamer A, Lutz J, Loughlin GM (1994) Determinants of growth in children with the obstructive sleep apnea syndrome. J Pediatr 125:556–562PubMedCrossRef
28.
Cheng PW, Fang KM, Su HW, Huang TW (2012) Improved objective outcomes and quality of life after adenotonsillectomy with inferior turbinate reduction in pediatric obstructive sleep apnea with inferior turbinate hypertrophy. Laryngoscope 122:2850–2854PubMedCrossRef
29.
Jeyakumar A, Fettman N, Armbrecht ES, Mitchell R (2011) A systematic review of adenotonsillectomy as a risk factor for childhood obesity. Otolaryngol Head Neck Surg 144:154–158PubMedCrossRef
30.
Roemmich JN, Barkley JE, D’Andrea L, Nikova M, Rogol AD, Carskadon MA, Suratt PM (2006) Increases in overweight after adenotonsillectomy in overweight children with obstructive sleep-disordered breathing are associated with decreases in motor activity and hyperactivity. Pediatrics 17:200–208CrossRef
31.
Nieminen P, Löppönen T, Tolonen U, Lanning P, Knip M, Löppönen H (2002) Growth and biochemical markers of growth in children with snoring and obstructive sleep apnea. Pediatrics 109:e55PubMedCrossRef
32.
Villa MP, Miano S (2012) Mandibular advancement devices. In: Kheirandish-Gozal L, Gozal D (eds) Sleep disordered breathing in children: a comprehensive clinical guide to evaluation and treatment. Heidelberg: Humana Press, New York, pp 542–551
33.
Villa MP, Bertarini A, Pagani J, Paggi B, Montesano M, Alterio A, Cerone E, Masieri S, Ronchetti R (2001) Terapia miofunzionale in bambini con ostruzione delle alte vie respiratorie. RIP 27:229–236
34.
Guimarães KC, Drager LF, Genta PR, Marcondes BF, Lorenzi-Filho G (2009) Effects of oropharyngeal exercises on patients with moderate obstructive sleep apnea syndrome. Am J Respir Crit Care Med 179:962–966PubMedCrossRef
35.
Guilleminault C, Huang YS, Monteyrol PJ, Sato R, Quo S, Lin CH. Critical role of myofascial reeducation in pediatric sleep-disordered breathing. Sleep Med 14:518–525
36.
Huang YS, Guilleminault C (2012) Pediatric obstructive sleep apnea and the critical role of oral–facial growth: evidences. Front Neurol 3:184PubMedCentralPubMed
Metadata
Title
Adenotonsillectomy and orthodontic therapy in pediatric obstructive sleep apnea
Authors
Maria Pia Villa
Rosa Castaldo
Silvia Miano
Maria Chiara Paolino
Ottavio Vitelli
Alessandra Tabarrini
Anna Rita Mazzotta
Manuela Cecili
Mario Barreto
Publication date
01-09-2014
Publisher
Springer Berlin Heidelberg
Published in
Sleep and Breathing / Issue 3/2014
Print ISSN: 1520-9512
Electronic ISSN: 1522-1709
DOI
https://doi.org/10.1007/s11325-013-0915-3

Other articles of this Issue 3/2014

Sleep and Breathing 3/2014 Go to the issue

Original Article

Correlation of daytime sleepiness with urine metabolites in patients with obstructive sleep apnea

Original Article

Prevalence and clinical correlates of sleep disordered breathing in myotonic dystrophy types 1 and 2

Original Article

Downregulation of uncoupling protein-1 mRNA expression and hypoadiponectinemia in a mouse model of sleep apnea

Original Article

Obstructive sleep apnea in Asian primary school children

Original Article

Association of ACE I/D polymorphism with obstructive sleep apnea susceptibility: evidence based on 2,228 subjects

Original Article

Post-operative outcomes in adult obstructive sleep apnea patients undergoing non-upper airway surgery: a systematic review and meta-analysis
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Reserve your place

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

Read more

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Pediatric Cardiology Video

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

Cardiopulmonary Comorbidity Video

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Valvular Heart Disease Video

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.

Watch now

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

16-04-2024 Type 2 Diabetes News

Incentivised to exercise

11-04-2024 Lifestyle Modifications News

New intervention for STEMI-related cardiogenic shock

10-04-2024 Myocardial Infarction News

» View more highlights on the ACC 2024 congress hub page

Image Credits